COVID-19 in breast cancer patients: a subanalysis of the OnCovid registry

*

Department of Medical Oncology, Vall d’Hebron University Hospital and Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain

*

Head Breast Cancer Unit, Vall d’Hebron University Hospital and Principal Investigator Breast Group, Vall d’Hebron Institute of Oncology (VHIO), Passeig Vall d’Hebrón 119-129, 08035 Barcelona, Spain

Department of Oncology and National Centre for HIV Malignancy, Chelsea and Westminster Hospital, London, UK

Department of Medical Oncology, Institute Gustave-Roussy, Villejuif, France

Department of Medical Oncology, UOC Clinica di Oncologia Medica, IRCCS Policlinico San Martino Hospital, Genoa, Italy

Department of Internal Medicine and Medical Specialties (DiMI), School of Medicine, University of Genova, Genoa, Italy

Cancer Division, University College London Hospitals, London, UK

Translational Oncology & Urology Research (TOUR), School of Cancer and Pharmaceutical Sciences, King’s College London, London, UK

Department of Medical Oncology, Catalan Institute of Oncology, L’Hospitalet, Spain

Oncobell Program (IDIBELL), CIBERONC, Hospitalet de Llobregat, Barcelona, Spain

Multidisciplinary Breast Pathology and Translational Research Unit, ASST Cremona, Casalmaggiore, Italy

Department of Medical Oncology, Hospital Clinic, Barcelona, Spain

Department of Medical Oncology, Catalan Institute of Oncology, University Hospital Josep Trueta, Girona, Spain

Department of Medical Oncology, Catalan Institute of Oncology, Badalona, Spain

Department Medical Oncology, Hospital XII de Octubre, Madrid, Spain

Medical Oncology Unit, Fondazione IRCCS Policlinico San Matteo, University of Pavia, Pavia, Italy

IRCCS Humanitas Research Hospital, Humanitas Cancer Center, Milan, Italy

Department of Biomedical Sciences, Humanitas University, Milan, Italy

Department of Biotechnology and Applied Clinical Sciences, University of L’Aquila, L’Aquila, Italy

Division of Surgery and Cancer, Hammersmith Hospital, Imperial College London, London, UK

Medical Oncology, Velindre Cancer Centre, Cardiff, UK

Medical Oncology, Velindre Cancer Centre, Cardiff, UK

Department of Oncology, Hospital Universitario Son Llatzer, Palma de Mallorca, Spain

Research Infrastructure, Research and Innovation Department, Azienda Ospedaliera “SS Antonio e Biagio e Cesare Arrigo”, Alessandria, Italy

Department of Oncology, University “Campus Bio-Medico”, Rome, Italy

Medical Oncology Unit, Fondazione Poliambulanza Istituto Ospedaliero, Brescia, Italy

Department of Oncology, Careggi University Hospital, Florence, Italy

Oncology Clinic, Università Politecnica Delle Marche, Ospedali Riuniti Di Ancona, Ancona, Italy

Struttura Complessa di Oncologia Medica e Traslazionale, Azienda Ospedaliera Santa Maria di Terni, Italy

Department of Gynecology and Obstetrics, Breast Center and Gynecological Cancer Center and CCC Munich, University Hospital Munich, Munich, Germany

Department of Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Belgium

Department of Oncology and National Centre for HIV Malignancy, Chelsea and Westminster Hospital, London, UK

Department of Medical Oncology, Vall d’Hebron University Hospital and Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain

Department of Infectious Diseases, Vall d’Hebron University Hospital, Barcelona, Spain

Department of Oncology, Hospital Althaia Manresa, Barcelona, Spain

Department of Translational Medicine, University of Piemonte Orientale, Azienda Ospedaliero-Universitaria Maggiore della Carità, Novara, Italy

Cancer Division, University College London Hospitals, London, UK

Medical Oncology, Barts Health NHS Trust, London, UK

Translational Oncology & Urology Research (TOUR), School of Cancer and Pharmaceutical Sciences, King’s College London, London, UK

Department of Medical Oncology, Catalan Institute of Oncology, L’Hospitalet (Barcelona), Spain

Multidisciplinary Breast Pathology and Translational Research Unit, ASST Cremona, Casalmaggiore, Italy

Department of Medical Oncology, Hospital Clinic, Barcelona, Spain

Translational Genomics and Targeted therapies Group, IDIBAPS, Barcelona, Spain

Department of Medical Oncology, Catalan Institute of Oncology, University Hospital Josep Trueta, Girona, Spain

IRCCS Humanitas Research Hospital, Humanitas Cancer Center, Milan, Italy

Department of Biomedical Sciences, Humanitas University, Milan, Italy

Breast Unit, IRCCS Policlinico San Martino Hospital, Genoa, Italy

Department of Internal Medicine and Medical Specialties (DiMI), School of Medicine, University of Genova, Genoa, Italy

Medical Oncology Unit, San Salvatore Hospital, L’Aquila, Italy

Department of Oncology and National Centre for HIV Malignancy, Chelsea and Westminster Hospital, London, UK

Department of Infectious Diseases, Vall d’Hebron University Hospital, Barcelona, Spain

Division of Radiotherapy, Department of Translational Medicine, University of Eastern Piedmont and Hospital “Maggiore della Carità”, Novara, Italy

Cancer Division, University College London Hospitals, London, UK

Department of Medical Oncology, Catalan Institute of Oncology, Badalona, Spain

Department of Medical Oncology, Catalan Institute of Oncology, L’Hospitalet (Barcelona), Spain

Oncobell Program (IDIBELL), CIBERONC. Hospitalet de Llobregat, Spain

Department of Oncology, Hospital Althaia Manresa, Barcelona, Spain

Department of Translational Medicine, University of Piemonte Orientale, Azienda Ospedaliero-Universitaria Maggiore della Carità, Novara, Italy

Multidisciplinary Breast Pathology and Translational Research Unit, ASST Cremona, Casalmaggiore, Italy

Department of Medical Oncology, Institute Gustave-Roussy, Villejuif, France

Department of Biomedical Sciences and Human Oncology, University of Bari Aldo Moro, Bari, Italy

Medical Oncology Unit, Fondazione IRCCS Policlinico San Matteo, University of Pavia, Pavia, Italy

Department of Gynecology and Obstetrics, Breast Center and Gynecological Cancer Center and CCC Munich, University Hospital Munich, Munich, Germany

Department of Translational Medicine, Unit of Medical Statistics, University of Piemonte Orientale and Cancer Epidemiology, CPO Piemonte, Novara, Italy

Division of Surgery and Cancer, Hammersmith Hospital, Imperial College London, London, UK

Department of Translational Medicine, University of Piemonte Orientale, Azienda Ospedaliero-Universitaria Maggiore della Carità, Novara, Italy

Department of Translational Medicine, University of Piemonte Orientale, Azienda Ospedaliero-Universitaria Maggiore della Carità, Novara, Italy

Department of Surgery and Cancer, Imperial College London, London, UK

on behalf of the OnCovid study group

*Both authors contributed equally as first authors.

†Both authors contributed equally as last authors.

Corresponding Author:

留言 (0)

沒有登入
gif